RAP 0.00% 20.5¢ resapp health limited

Ann: Healthcare Leaders Appointed to Industry Advisory Board, page-2

  1. 5,349 Posts.
    lightbulb Created with Sketch. 1178
    Tony Keating, CEO and Managing Director of ResApp commented, “As we begin the global commercialisation of our products, we are excited to announce the formation of our Industry Advisory Board. Both Dr Fried and Dr Kvedar are incredibly talented and experienced professionals who are recognised leaders in digital health and bring a vast amount of experience from within the US healthcare system. We are confident that ResApp will benefit greatly from their insights, judgment and counsel.”

 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.